Page last updated: 2024-11-03

quipazine and Huntington Disease

quipazine has been researched along with Huntington Disease in 1 studies

Quipazine: A pharmacologic congener of serotonin that contracts smooth muscle and has actions similar to those of tricyclic antidepressants. It has been proposed as an oxytocic.

Huntington Disease: A familial disorder inherited as an autosomal dominant trait and characterized by the onset of progressive CHOREA and DEMENTIA in the fourth or fifth decade of life. Common initial manifestations include paranoia; poor impulse control; DEPRESSION; HALLUCINATIONS; and DELUSIONS. Eventually intellectual impairment; loss of fine motor control; ATHETOSIS; and diffuse chorea involving axial and limb musculature develops, leading to a vegetative state within 10-15 years of disease onset. The juvenile variant has a more fulminant course including SEIZURES; ATAXIA; dementia; and chorea. (From Adams et al., Principles of Neurology, 6th ed, pp1060-4)

Research Excerpts

ExcerptRelevanceReference
"Quipazine was instead competent to increase plasma cortisol levels in 6/8 normal subjects."1.26Neuroendocrine effects of quipazine in man in health state or with neurological disorders. ( Caraceni, T; Cocchi, D; Müller, EE; Parati, EA; Zanardi, P, 1980)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Parati, EA1
Zanardi, P1
Cocchi, D1
Caraceni, T1
Müller, EE1

Other Studies

1 other study available for quipazine and Huntington Disease

ArticleYear
Neuroendocrine effects of quipazine in man in health state or with neurological disorders.
    Journal of neural transmission, 1980, Volume: 47, Issue:4

    Topics: Adult; Cluster Headache; Epilepsies, Myoclonic; Female; Follicle Stimulating Hormone; Growth Hormone

1980